Innate Pharma SA banner

Innate Pharma SA
PAR:IPH

Watchlist Manager
Innate Pharma SA Logo
Innate Pharma SA
PAR:IPH
Watchlist
Price: 1.584 EUR -1.74%
Market Cap: €148.8m

Multiples-Based Value

The Multiples-Based Value for Innate Pharma SA (IPH) under the Base Case is 0.522 EUR. Compared with the current market price of 1.584 EUR, the stock appears Overvalued by 67% .

Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

IPH Multiples-Based Value
0.522 EUR
Overvaluation 67%
Multiples-Based Value
Price €1.584
Bear Case
Base Case
Bull Case

Multiples Across Competitors

IPH Competitors Multiples
Innate Pharma SA Competitors

Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett